임상시험

InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy

NCT: NCT06411548 · COMPLETED

NCT IDNCT06411548

상태COMPLETED

시작일2025-03-27

완료2025-10-17

SponsorUniversity of Virginia (OTHER)

First posted2024-05-13

Last updated2026-05-14

간략 요약

This is a 24-hour, randomized, crossover, single-center trial where participants are randomized to either start with the InsuLearn intervention or the usual care (UC) intervention. In the InsuLearn intervention, insulin doses are optimized using data collected in a 4-weeks at home data collection period.

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.